Adrenal Gland Disorders |
Adrenal Disease; Disorder |
Clinical Trial: Heart Disease Risk Factors in Major Depression
This study is currently recruiting patients.
|
Purpose
The purpose of this study is to understand why depressed people have a greater chance of developing heart disease than people who are not depressed. This study will examine insulin resistance in participants with major depression to determine how severe it is and why it occurs.
People with major depression have an increased risk for coronary artery disease. This increased risk may be a result of hormonal changes that occur with depression. Insulin resistance may be associated with these hormonal changes. This study will determine whether insulin resistance is an underlying mechanism that predisposes people with major depression to ischemic heart disease.
Participants will be screened with a medical and psychiatric history, a physical examination, blood and urine tests, and an electrocardiogram. A control group of healthy volunteers will also be recruited as a comparison group.
| Condition |
|---|
| Adrenal Gland Hyperfunction Cardiovascular Disease Involutional Depression |
MedlinePlus related topics: Adrenal Gland Disorders; Heart Diseases; Mental Health; Vascular Diseases
Study Type: Observational
Study Design: Natural History
Official Title: Factors in Susceptibility to Ischemic Heart Disease in Major Depression: Documentation of Insulin Resistance in Patients with Major Depression Utilizing the Hyperinsulinemic Euglycemic Glucose Clamp
Expected Total Enrollment: 80
Study start: December 30, 1999
A series of studies in patients with major depression have consistently demonstrated a doubling of the mortality rate at any age, independent of suicide. In addition, the relative risk for clinically significant coronary artery disease in patients with major depression is also 2 or even higher in studies that are independently controlled for risk factors such as smoking, hypertension, etc. The principal long-term goals of the CNE include the determination of the mechanisms that underlie enhanced susceptibility to premature ischemic heart disease in patients with major depression, documenting the age at which demonstrable pathophysiologic or predictive changes begin to occur, and charting their rate of progression. Our long-term goal is to use our understanding of underlying mechanisms to enhance our capacity to predict who with major depression is most likely to develop premature ischemic heart disease, to determine the age of this susceptibility, and to develop improved means for treatment and prevention. While there are numerous risk factors for coronary artery disease and we plan to study them as well in our serial protocols, in this protocol, we propose to study insulin resistance as an underlying mechanism that predisposes patients with major depression to ischemic heart disease.
Eligibility
Genders Eligible for Study: Both
Accepts Healthy Volunteers
Criteria
Men and women, from all ethnic backgrounds, between 18 and 65 years old who have had a history of any types of major depression or are currently depressed will be eligible for this study, provided they are free from the conditions described in the exclusion criteria. Candidates will be screened with a complete medical and psychiatric history and physical examination, as well as blood and urine tests, and electrocardiogram. Healthy volunteers will also be recruited to this study to serve as a control group. Volunteers will be matched to each patient in the study according to age, gender, body weight and height, and will undergo the same screening and study procedures.
Females must not be pregnant.
Subjects must not have diabetes mellitus.
Subjects must not have cardiovascular, renal, hepatic and other end organ diseases.
Subjects must not have peripheral vascular disease.
Subjects must not have any inflammatory diseases.
Subjects must not have HIV infection.
Subjects must not be on beta-blockers, thiazides, and/or glucocorticoids.
Subjects must have BMI of 29 or less.
Location and Contact Information
Maryland
National Institute of Mental Health (NIMH), 9000 Rockville Pike, Bethesda, Maryland, 20892, United States; Recruiting
More Information
Detailed Web Page
Publications
Barefoot JC, Helms MJ, Mark DB, Blumenthal JA, Califf RM, Haney TL, O'Connor CM, Siegler IC, Williams RB. Depression and long-term mortality risk in patients with coronary artery disease. Am J Cardiol. 1996 Sep 15;78(6):613-7.
Glassman AH, Shapiro PA. Depression and the course of coronary artery disease. Am J Psychiatry. 1998 Jan;155(1):4-11. Review.
Anda RF, Williamson DF, Escobedo LG, Mast EE, Giovino GA, Remington PL. Depression and the dynamics of smoking. A national perspective. JAMA. 1990 Sep 26;264(12):1541-5.
Record last reviewed: November 4, 2003
Last Updated: November 23, 2004
Record first received: January 18, 2000
ClinicalTrials.gov Identifier: NCT00001969
Health Authority: United States: Federal Government
ClinicalTrials.gov processed this record on 2005-04-08
Source: ClinicalTrials.gov
Cache Date: April 9, 2005
Resources
- AACE Physician Finder (American Association of Clinical Endocrinologists)
- ACTH (Adrenocorticotropic Hormone) Test (American Association for Clinical Chemistry)

Not Signed In -

